Guardant Health, Inc.
GH
$25.36
-$0.88-3.35%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 168.49M | 155.05M | 143.03M | 137.15M | 128.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 168.49M | 155.05M | 143.03M | 137.15M | 128.71M |
| Cost of Revenue | 65.30M | 62.52M | 57.61M | 53.85M | 53.07M |
| Gross Profit | 103.20M | 92.54M | 85.42M | 83.30M | 75.64M |
| SG&A Expenses | 119.08M | 117.02M | 105.11M | 112.56M | 116.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.17M | 268.90M | 256.07M | 256.27M | 262.77M |
| Operating Income | -99.68M | -113.84M | -113.04M | -119.12M | -134.06M |
| Income Before Tax | -114.58M | -187.58M | -85.61M | -72.28M | -133.29M |
| Income Tax Expenses | 405.00K | -541.00K | 490.00K | 496.00K | 240.00K |
| Earnings from Continuing Operations | -114.99M | -187.04M | -86.10M | -72.77M | -133.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -114.99M | -187.04M | -86.10M | -72.77M | -133.53M |
| EBIT | -99.68M | -113.84M | -113.04M | -119.12M | -134.06M |
| EBITDA | -88.97M | -102.97M | -102.01M | -108.49M | -123.71M |
| EPS Basic | -0.94 | -1.58 | -0.73 | -0.67 | -1.30 |
| Normalized Basic EPS | -0.43 | -0.52 | -0.54 | -0.41 | -0.80 |
| EPS Diluted | -0.94 | -1.58 | -0.73 | -0.67 | -1.30 |
| Normalized Diluted EPS | -0.43 | -0.52 | -0.54 | -0.41 | -0.80 |
| Average Basic Shares Outstanding | 121.71M | 118.51M | 117.74M | 108.81M | 102.66M |
| Average Diluted Shares Outstanding | 121.71M | 118.51M | 117.74M | 108.81M | 102.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
